PET/CT Doctors Abroad — Page 2

Dr. Zhang Yanjun is a Chief Physician at Jinshazhou Hospital who specializes in tumor imaging and radiation oncology. She brings senior clinical expertise to PET/CT diagnostics for complex cancer cases.

• Trained as a visiting scholar at two top-tier radiation therapy hospitals in the United States
• Published 46 academic papers on tumor diagnosis in international medical journals
• Member of the Central Nervous System Tumor Radiotherapy Group for the Chinese Medical Doctor Association
• Expert in identifying primary and secondary tumors in both children and adult patients

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Professor Ido Nachmany is a Forbes-recognized top physician at Sheba Medical Center. He heads the general surgery department and specializes in complex tumor diagnostics including PET/CT scans.

• Expert in gastrointestinal neuroendocrine tumors – rare cancers requiring precise PET/CT staging
• Fellowship trained at the Thomas E. Starzl Transplantation Institute in the USA
• Senior Lecturer at Tel Aviv University faculty of medicine
• Member of the International Hepato-Pancreato-Biliary Association
• Published researcher in surgical oncology and medical imaging for cancer detection

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.

• Specializes in conformal treatments for complex tumor cases.
• Treats various conditions including lung, breast, and brain tumors.
• Practices at a JCI-accredited hospital that serves 200,000 patients annually.
• Completed his radiation oncology training at the Istanbul University Cerrahpaşa Faculty.

Dr. Altay Aliyev is a clinical oncologist at Liv Bona Dea Hospital Baku. He specializes in chemotherapy, immunotherapy, and targeted treatments for various cancers. Dr. Aliyev completed a fellowship as a research associate at the Cleveland Clinic. He treats complex conditions like glioblastoma, metastatic breast cancer, and colorectal tumors.

• Expertise covers cytotoxic chemotherapy, hormone therapy, and palliative oncological care.
• Published research on tumor markers in thyroid cancer and breast cancer chemotherapy.
• Formerly served as a research associate in the Cleveland Clinic Endocrinology Department.
• Practices at Liv Bona Dea Hospital, a JCI-accredited facility in Azerbaijan.

Dr. Almog Ben Yaacov is a senior oncological surgeon at Sheba Medical Center. He completed advanced surgical oncology training at Memorial Sloan Kettering Cancer Center in New York.

• Specializes in complex abdominal cancers where PET/CT is vital for surgical planning
• Trained in NanoKnife technology at King’s College London for treating difficult tumors
• Performed over 200 HIPEC procedures to treat advanced abdominal wall metastases
• Graduated with honors and holds board certifications in both general and surgical oncology

Professor Amit Tirosh leads the neuroendocrine tumor service at Sheba Medical Center. He specializes in using PET/CT scans to track and treat complex endocrine cancers.

• Trained in neuroendocrine tumors at the National Institutes of Health in the USA
• Provides peptide receptor radionuclide therapy – a targeted treatment for advanced cancer cases
• Expert panelist for international VHL disease guidelines – a rare genetic cancer syndrome
• Published research on Gallium-68 DOTATATE – a specialized radioactive tracer for neuroendocrine PET/CT
• Member of the European Neuroendocrine Tumors Society

Dr. David Kuczer is a specialist in radio-oncology and radiotherapy. He leads cancer diagnostics at Amethyst Radiotherapy at the Vienna Private Clinic.

• Coordinates cases with an interdisciplinary tumor board for expert review
• Specializes in using PET/CT for precise cancer diagnosis and treatment planning
• Member of the Cancer Center of the Vienna Private Clinic
• Provides rapid access to imaging results according to scientific standards
• Works with an internationally recognized team of oncology experts

Dr. Dov Zippel is a surgical oncologist and head of the Meirav Breast Center. Forbes Israel named him to its Best Doctors list in 2025. He treats benign and malignant breast tumors and melanoma at Sheba Medical Center. Dr. Zippel completed a surgical oncology fellowship at the University of Calgary in Canada.

• Performs breast-conserving surgery and minimally invasive skin cancer procedures.
• Treats patients at the Ella Lemelbaum Institute for Immuno-Oncology.
• Researches perioperative treatments for stage III melanoma and breast lesion excision.
• Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.

Dr. Zvi Cohen is the Director of the Neurosurgery Department at Sheba Medical Center. He was recently recognized in Forbes Israel’s Best Doctors list for 2025. Dr. Cohen specializes in treating complex brain, pituitary, and spinal cord tumors. He founded the brain tumor tissue bank at Sheba to support oncological research. Dr. Cohen is board-certified in neurosurgery and leads clinical trials for malignant brain tumors.

• Completed fellowships in neurosurgical oncology at MD Anderson and neuroradiology at Beth Israel.
• Expert in intraoperative MRI, stereotactic biopsies, and image-guided resections.
• Performs radiosurgery and minimally invasive microsurgery for CNS tumors.
• Member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Antonio Alcaraz is a lead uro-oncologist at Hospital Quiron Barcelona. He specializes in the surgical treatment of prostate, bladder, and kidney cancers often detected via PET/CT scans.

• Performed over 500 successful operations for urogenital pathologies.
• World first surgeon to perform transvaginal NOTES nephrectomy through natural body openings.
• Heads the Urology Department at Teknon Medical Center in Barcelona.
• Uses the Da Vinci robotic system for high-precision tumor removals.
• Holds a Hirsch index of 27 reflecting significant contributions to medical research.

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Jaume Mora Graupera leads pediatric oncology at SJD Barcelona Children’s Hospital. He specialized in pediatric cancer at Memorial Sloan Kettering Cancer Center.

• Coordinates oncologic imaging including PET/CT for pediatric sarcomas and brain tumors
• Scientific Director of the Hematology Oncology Department in Barcelona
• Developed non-radiative treatments to protect the developing nervous systems of children
• Authored over 70 scientific papers investigating advanced childhood cancer treatments
• Awarded the Schweisguth Prize by the International Society of Pediatric Oncology

Dr. Sinan Karaaslan is a Doctor of Medical Sciences at Anadolu Medical Center. He uses detailed PET/CT results to plan systemic therapies for complex cancer cases.

• Specializes in stage 4 lung and colon cancer treatments
• Member of the Turkish Lung Cancer Society
• Trained at Istanbul University – one of Turkey's top medical schools
• Expert in targeted therapy and immunotherapy for advanced malignancies
• Former oncology expert at the Gülhane Military Medical Academy

Professor Yesim Yildirim is an ESMO-certified medical oncologist at Anadolu Medical Center. She uses PET/CT imaging to manage breast, lung, and gastrointestinal cancers.

• Completed advanced oncology training at Rambam Medical Center in Israel
• Specialized in immunooncology at Mount Vernon Cancer Center in the UK
• Authored over 80 scientific works on precision medicine and cancer care
• Founded the Turkish Gastrointestinal Oncology Network to improve specialist collaboration
• Member of the American Society of Clinical Oncology (ASCO)

Dr. Rahib Hasanov is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a prestigious observership program at Houston Methodist Hospital in Texas. Dr. Hasanov specializes in personalized oncology using immunotherapy and targeted therapies. He treats a wide range of conditions including gastrointestinal, breast, and lung cancers.

• Expertise includes targeted therapies and novel agents for stage 4 cancers.
• Treats complex urogenital system tumors, including prostate and ovarian cancers.
• Practices at JCI-accredited Hisar Hospital, a center treating 250,000 patients annually.
• Member of the Turkish medical community with international training in the US.

Professor Seref Komurcu is an ESMO-certified oncologist at Anadolu Medical Center. He utilizes PET/CT imaging to guide systemic therapies for various solid tumors.

• Authored over 110 scientific papers on cancer treatment protocols
• Certified by the European Society for Medical Oncology (ESMO)
• Held a professorship at the Gülhane Military Medical Academy for years
• Specializes in using targeted therapies and immunotherapy for lung and breast cancers
• Active member of the American Society of Clinical Oncology (ASCO)